![](20211015C99FC98555A00001EAC7B1A73774BC60_139661263_1610433876388.jpg)
Residents walks to receive nucleic acid test in Tiexi District of Shenyang, northeast China's Liaoning Province, Jan. 11, 2021. Shenyang is conducting a third round of nucleic acid tests for all residents in Tiexi, Huanggu and Yuhong districts, starting Monday. (Xinhua/Yang Qing)
![](\pageflag.gif)
A community volunteer works at a nucleic acid test site in Tiexi District of Shenyang, northeast China's Liaoning Province, Jan. 11, 2021. Shenyang is conducting a third round of nucleic acid tests for all residents in Tiexi, Huanggu and Yuhong districts, starting Monday. (Xinhua/Yang Qing)
![](\pageflag.gif)
A medical worker collects a swab sample from a resident at a nucleic acid test site in Tiexi District of Shenyang, northeast China's Liaoning Province, Jan. 11, 2021. Shenyang is conducting a third round of nucleic acid tests for all residents in Tiexi, Huanggu and Yuhong districts, starting Monday. (Xinhua/Yang Qing)
![](\pageflag.gif)
Shenyang conducts 3rd round of nucleic acid tests for all residents in 3 districts
Residents wait in line for nucleic acid tests in Yuhong District of Shenyang, northeast China's Liaoning Province, Jan. 11, 2021. Shenyang is conducting a third round of nucleic acid tests for all residents in Tiexi, Huanggu and Yuhong districts, starting Monday. (Xinhua/Yao Jianfeng)
![](\pageflag.gif)
Residents wait in line for nucleic acid tests in Huanggu District of Shenyang, northeast China's Liaoning Province, Jan. 11, 2021. Shenyang is conducting a third round of nucleic acid tests for all residents in Tiexi, Huanggu and Yuhong districts, starting Monday. (Xinhua/Yao Jianfeng)